Greenwich LifeSciences Presents FLAMINGO-01 Phase III Trial Open Label Data Published at ASCO Meeting 2026

Go back to Greenwich LifeSciences Presents FLAMINGO-01 Phase III Trial Open Label Data Published at ASCO Meeting 2026
(NASDAQ: GLSI) Delayed: 16.67 +1.36 (8.88%)
Previous Close $15.31    52 Week High
Open $16.16    52 Week Low
Day High $17.48    P/E N/A 
Day Low $15.54    EPS
Volume 176,697